Three nonnucleoside reverse transcriptase inhibitor-sparing antiretroviral regimens for treatment-naive volunteers infected with HIV-1

Ann Intern Med. 2015 Mar 17;162(6):461-2. doi: 10.7326/L15-5066-3.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Female
  • HIV Infections / drug therapy*
  • HIV Protease Inhibitors / therapeutic use*
  • HIV-1*
  • Humans
  • Male

Substances

  • HIV Protease Inhibitors